Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report) shares saw strong trading volume on Friday . 124,502 shares changed hands during mid-day trading, a decline of 3% from the previous session’s volume of 128,801 shares.The stock last traded at $108.0950 and had previously closed at $107.35.
Wall Street Analyst Weigh In
Separately, Weiss Ratings downgraded Mesa Laboratories from a “sell (d+)” rating to a “sell (d)” rating in a report on Wednesday, June 3rd. Two analysts have rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Reduce” and a consensus target price of $94.00.
View Our Latest Research Report on MLAB
Mesa Laboratories Stock Up 0.0%
Mesa Laboratories (NASDAQ:MLAB – Get Free Report) last posted its earnings results on Wednesday, May 27th. The medical instruments supplier reported $1.53 earnings per share for the quarter, missing analysts’ consensus estimates of $1.78 by ($0.25). Mesa Laboratories had a return on equity of 20.96% and a net margin of 2.69%.The firm had revenue of $63.72 million for the quarter, compared to analyst estimates of $65.21 million. During the same period in the prior year, the business posted ($1.31) EPS. As a group, sell-side analysts expect that Mesa Laboratories, Inc. will post 8.74 EPS for the current year.
Mesa Laboratories Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Stockholders of record on Friday, May 29th will be issued a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, May 29th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.6%. Mesa Laboratories’s dividend payout ratio (DPR) is currently 53.33%.
Institutional Inflows and Outflows
Hedge funds have recently modified their holdings of the stock. Northwestern Mutual Wealth Management Co. increased its position in shares of Mesa Laboratories by 5,366.7% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 328 shares of the medical instruments supplier’s stock worth $26,000 after purchasing an additional 322 shares during the period. Caitong International Asset Management Co. Ltd bought a new position in shares of Mesa Laboratories in the fourth quarter worth $27,000. Kestra Advisory Services LLC bought a new position in shares of Mesa Laboratories in the fourth quarter worth $55,000. BNP Paribas Financial Markets increased its position in shares of Mesa Laboratories by 30.9% in the third quarter. BNP Paribas Financial Markets now owns 1,029 shares of the medical instruments supplier’s stock worth $69,000 after purchasing an additional 243 shares during the period. Finally, Tower Research Capital LLC TRC increased its position in shares of Mesa Laboratories by 432.9% in the second quarter. Tower Research Capital LLC TRC now owns 842 shares of the medical instruments supplier’s stock worth $79,000 after purchasing an additional 684 shares during the period. Institutional investors own 90.60% of the company’s stock.
About Mesa Laboratories
Mesa Laboratories, Inc (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes.
The company’s product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications.
Recommended Stories
- Five stocks we like better than Mesa Laboratories
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
- ERock IPO: A $1.3B Power Play Solution
Receive News & Ratings for Mesa Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
